SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001583648-18-000005
Filing Date
2018-02-09
Accepted
2018-02-09 07:41:15
Documents
6
Period of Report
2018-02-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm 8-K 28631
2 EXHIBIT 99.1 a180208finalpierisseagen.htm EX-99.1 12890
3 a180208finalpierisseagen001.jpg GRAPHIC 246667
4 a180208finalpierisseagen002.jpg GRAPHIC 237395
5 a180208finalpierisseagen003.jpg GRAPHIC 270828
6 a180208finalpierisseagen004.jpg GRAPHIC 87863
  Complete submission text file 0001583648-18-000005.txt   1190692
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 18587749
SIC: 8731 Services-Commercial Physical & Biological Research